Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001604950-17-000001
Filing Date
2017-01-06
Accepted
2017-01-06 16:08:30
Documents
1
Effectiveness Date
2017-01-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12300
  Complete submission text file 0001604950-17-000001.txt   13355
Mailing Address 75 ARLINGTON STREET SUITE 500 BOSTON MA 02116
Business Address 75 ARLINGTON STREET SUITE 500 BOSTON MA 02116 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-277857 | Film No.: 17514408